Business
VSee Health Announces Filing Second Quarter 2025 Results
SAN JOSE, CA / ACCESS Newswire / October 17, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leader in telehealth solutions, reported its financial results for the three months ended June 30, 2025 ("Second Quarter 2025"). Unless otherwise noted, percentage ...
About this update from Vsee Health, Inc.
[{"type":"text","content":"SAN JOSE, CA / ACCESS Newswire / October 17, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leader in telehealth solutions, reported its financial results for the three months ended June 30, 2025 ("Second Quarter 2025"). Unless otherwise noted, percentage and other changes are relative to the three months ended June 30, 2024 ("Second Quarter 2024").","length":366,"tagName":"p"},{"type":"text","content":"Highlights","length":10,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Second Quarter 2025 revenue of $3.4 million, up 98% year-over-year","length":66,"tagName":"p"}]},{"val":[{"type":"text","content":"Second Quarter 2025 Gross profit margin increased from 45% to 47%","length":65,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":131,"olType":false},{"type":"text","content":"Liquidity and Cash Flow","length":23,"tagName":"p"},{"type":"text","content":"Cash flow used in operations was $765,094 in the first six months of 2025, compared to $2,594,214 in the first six months of 2024. Cash flow used in investing activities was $15,466 for the first six months of 2025, compared to $16,390 in the first six months of 2024. Cash flow from financing activities was $746,040 in the first six months of 2025, compared to $3,597,841 in the first six months of 2024.","length":406,"tagName":"p"},{"type":"text","content":"The integration of iDoc Telehealth has been challenging yet the rewards of robust revenue growth, expanded customer relationships and operational progress should provide comfort to shareholders and interested parties alike that the Company is on the right path. The Company's is experiencing more than 100% year-over-year revenue growth which has been largely driven by the acquisition of iDoc and the growth of the Company's telehealth service. With the consolidation of VSee Lab and iDoc platforms, aligning physician coverage, service offerings, and client delivery models the Company believes both revenue growth and operational efficiencies will deliver monumental operational improvements for the near future. Finally, new clients have provided strong revenue growth and expansion into new services has improved gross margins, management is not yet satisfied and is committed to build shareholder value.","length":917,"tagName":"p"},{"type":"text","content":""We are extreme...